West Pharmaceutical Services Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Total Cash from Operations: $460.2M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $126.4M | 27.5% |
| Business Acquisitions | $18.9M | 4.1% |
| Other Investing | $82.7M | 18.0% |
| Dividends Paid | $45.1M | 9.8% |
| Stock Repurchases | $83.1M | 18.1% |
| Working Capital | $2.3M | 0.5% |
| Net Cash Flow | $101.7M | 22.1% |